Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA), after posting better than expected results at a time when it has come to known as controversial and volatile, is now attracting news analysts’ sentiments. Yet the company is also blowing its own trumpet and placing a lot of hopes in its recently re-launched leukemia drug Iclusig. Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA) stock opened at $8.48 in last session, and closed at $8.99, while the day range of ARIA stock is $8.22-9.05.The stock showed a positive weekly performance of 2.98%.
FuelCell Energy Inc (NASDAQ:FCEL)’s shares gained 5.36% to $1.77. The FuelCell Energy Inc (NASDAQ:FCEL) announced it will release its first quarter financial results after the Market Close on Monday, March 10, 2014. FuelCell Energy management will host a conference call with investors beginning at 10:00 a.m. Eastern Time on Tuesday, March 11, 2014 to discuss the first quarter results for 2014. FuelCell Energy Inc (NASDAQ:FCEL) stock opened at $1.85, in last session and closed at $1.92, by gained 6.08%.The 52 week range was $0.84-$1.96.Company’s market capitalization is $394.33 million.
Pharmaceutical company Mylan (NASDAQ:MYL) reported Q4 adjusted earnings above expectations on revenue that met the Street view, and forecast 2014 earnings in line with analysts’ estimates while giving upbeat revenue guidance for the year. Mylan Inc (NASDAQ:MYL) stock gained 9.43% and finished the last session at $56.27.The EPS of the stock remained 1.52.Company’s market capitalization is $21.54 billion.
First Solar Inc. (Nasdaq: FSLR) reported Q4 adjusted earnings of $0.89 per share on revenue of $768 million. Analysts surveyed by FactSet had projected earnings per share (EPS) of $0.98 on revenue of $973 million. First Solar, Inc. (NASDAQ:FSLR) stock opened the session at $54.08, and closed the session at $57.19.The 52 week range of the FSLR stock remained $24.26-$65.99 and the day range was $54.00-$57.30.